Free Trial
OTCMKTS:NVZMY

Novozymes A/S (NVZMY) Stock Price, News & Analysis

Novozymes A/S logo
$71.64 -0.69 (-0.95%)
As of 06/30/2025 03:59 PM Eastern

About Novozymes A/S Stock (OTCMKTS:NVZMY)

Key Stats

Today's Range
$70.94
$71.75
50-Day Range
$62.00
$75.47
52-Week Range
$53.95
$75.99
Volume
8,021 shs
Average Volume
19,678 shs
Market Capitalization
$33.55 billion
P/E Ratio
45.34
Dividend Yield
1.06%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Novozymes A/S is a global biotechnology company headquartered in Bagsværd, Denmark, specializing in the research, development and production of industrial enzymes and microorganisms. Since its spin-off from Novo Nordisk in 2000, Novozymes has become a leading supplier of biological solutions designed to enhance process efficiency, sustainability and resource utilization across a wide range of industries.

The company’s core offerings include enzyme formulations for applications in agriculture, bioenergy, food and beverages, household care, textile processing, pulp and paper, animal feed and waste treatment. By tailoring its biocatalysts to customer needs, Novozymes helps manufacturers lower energy and water consumption, reduce chemical usage and improve product quality. Key product lines include feed enzymes that support animal nutrition, cellulases for bioethanol production and amylases for starch conversion in food processing.

Novozymes serves customers in more than 100 countries, operating production facilities and application centers in Europe, North America, South America and Asia-Pacific. The company’s global footprint supports close collaboration with multinational corporations and local enterprises alike, enabling rapid adoption of enzyme technologies. Under the leadership of CEO Ester Baiget, who took the helm in 2021, Novozymes has continued to expand its market presence in emerging economies such as China, Brazil and India.

Research and development remain central to Novozymes’ strategy, with a workforce of scientists and engineers dedicated to discovering new biological solutions. The company invests heavily in sustainability initiatives, leveraging its expertise in fermentation and microbial engineering to develop climate-friendly processes. Through partnerships with industry, academia and public institutions, Novozymes aims to foster innovation that addresses global challenges such as food security, renewable energy and environmental protection.

AI Generated. May Contain Errors.

Novozymes A/S Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

NVZMY MarketRank™: 

Novozymes A/S scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Novozymes A/S are expected to grow by 17.58% in the coming year, from $1.82 to $2.14 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Novozymes A/S is 45.34, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.89.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Novozymes A/S is 45.34, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 89.50.

  • Price to Earnings Growth Ratio

    Novozymes A/S has a PEG Ratio of 1.37. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Novozymes A/S has a P/B Ratio of 2.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Novozymes A/S's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Novozymes A/S has been sold short.
  • Short Interest Ratio / Days to Cover

    Novozymes A/S has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Novozymes A/S has recently increased by 107.14%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Novozymes A/S pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Novozymes A/S does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Novozymes A/S is 48.10%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Novozymes A/S will have a dividend payout ratio of 35.51% next year. This indicates that Novozymes A/S will be able to sustain or increase its dividend.

  • Read more about Novozymes A/S's dividend.
  • Percentage of Shares Shorted

    0.00% of the float of Novozymes A/S has been sold short.
  • Short Interest Ratio / Days to Cover

    Novozymes A/S has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Novozymes A/S has recently increased by 107.14%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Novozymes A/S this week, compared to 1 article on an average week.
Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMY Stock News Headlines

NVZMY Novozymes A/S - Seeking Alpha
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this means and how everyday investors like you can position themselves to potentially profit. The timing couldn't be more critical
Novonesis A/S (NVZMY)
Novonesis price target lowered to DKK 490 from DKK 500 at Barclays
Invitation to the Annual General Meeting
Novonesis (Novozymes) B ADR
See More Headlines

NVZMY Stock Analysis - Frequently Asked Questions

Novozymes A/S's stock was trading at $56.5399 at the beginning of 2025. Since then, NVZMY stock has increased by 26.7% and is now trading at $71.64.
View the best growth stocks for 2025 here
.

Novozymes A/S (OTCMKTS:NVZMY) released its quarterly earnings results on Wednesday, January, 31st. The biotechnology company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by $0.11. The biotechnology company earned $664.46 million during the quarter.

The following companies are subsidiaries of Novozymes A/S: PrecisionBiotics Group Limited, OrganoBalance GmbH, Pacific Vet Group-USA, Allopartis, TJ Technologies, Iogen Bio-Products, Natural Industries, and others.

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
1/31/2024
Record date for 4/23 Dividend
4/07/2025
Ex-Dividend for 4/23 Dividend
4/07/2025
Dividend Payable
4/23/2025
Today
6/30/2025
Next Earnings (Estimated)
8/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
CHEM - SPECIALTY
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMY
Previous Symbol
OTC:NVZMY
Employees
10,582
Year Founded
2000

Profitability

Trailing P/E Ratio
45.34
Forward P/E Ratio
39.36
P/E Growth
1.37
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.15 billion
Cash Flow
$1.84 per share
Price / Cash Flow
38.95
Book Value
$25.82 per share
Price / Book
2.77

Miscellaneous

Free Float
N/A
Market Cap
$33.55 billion
Optionable
Not Optionable
Beta
0.92

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:NVZMY) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners